Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Pharma
Gilead's once-rejected hepatitis D med wins FDA nod
More than three years after Gilead's hepatitis D drug was rebuffed by the FDA on manufacturing concerns, the treatment has redeemed itself.
Fraiser Kansteiner
May 26, 2026 9:49am
Partnering to Advance Drug Delivery Innovation
Mar 12, 2026 1:00am
How BMS is Bringing Patient Friendly Therapies to Market
Feb 13, 2026 12:00am
PODD 2025 Patient Keynote: A Sickle Cell Patient’s Lived Experience with a Clinical Trial
Jan 28, 2026 12:00am
Sanofi’s Partnering Philosophy in Drug Delivery
Jan 28, 2026 12:00am
Platform Approaches to Streamline Combination Product Development
Jan 27, 2026 12:00am
